United States · FDA National Drug Code directory

levothyroxine sodium

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
68788-7698_0a8d16fa-f48c-44c3-b0b4-5e16b7e59421
Product NDC
68788-7698
Form
TABLET
Composition / generic term
levothyroxine sodium
Labeler
Preferred Pharmaceuticals, Inc.
Marketing category
NDA
Marketing start / end (source format)
20200401
Source listing expiry
20271231

Source-listed ingredients

  • LEVOTHYROXINE SODIUM — 50 ug/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 TABLET in 1 BOTTLE (68788-7698-3) · 68788-7698-3
  • 90 TABLET in 1 BOTTLE (68788-7698-9) · 68788-7698-9

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →